Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Strassmann

Showing results (61-70 of 84) with videos related to

Pageof 9
Sort By:
The Journal of Clinical Investigation|November 1, 1993
Suramin interferes with interleukin-6 receptor binding in vitro and inhibits colon-26-mediated experimental cancer cachexia in vivoG Strassmann, M Fong, C E Freter, et al.
Human Immunology|May 1, 1985
Analysis of human class II antigens by cloned cytolytic T cell reagents: a study using HLA loss mutant lymphoblastoid cell lines and monoclonal antibodies detecting the HLA-DP product(s)N Ohta, A Anichini, N L Reinsmoen, et al.
International Journal of Immunopharmacology|January 1, 1997
Vesnarinone inhibits immune-mediated but not Fas (CD95) agonist-mediated hepatic injuryD D Lazarus, T Kambayashi, M Yato-Kioka, et al.
Journal of the National Cancer Institute|September 18, 1996
Predominance of TH1 response in tumor-bearing mice and cancer patients treated with AS101B Sredni, T Tichler, A Shani, et al.
Annals of Surgical Oncology|January 1, 1996
Macrophage-derived tumor necrosis factor and tumor-derived of leukemia inhibitory factor and interleukin-6: possible cellular mechanisms of cancer cachexiaK G Billingsley, D L Fraker, G Strassmann, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 15, 1995
Effect of liposome-mediated macrophage depletion on LPS-induced cytokine gene expression and radioprotectionC A Salkowski, R Neta, T A Wynn, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1994
Inhibition of lipopolysaccharide and IL-1 but not of TNF-induced activation of human endothelial cells by suraminG Strassmann, N Graber, S M Goyert, et al.
Cardiovascular and Interventional Radiology|January 1, 1994
Prophylactic endovascular radiotherapy to prevent intimal hyperplasia after stent implantation in femoropopliteal arteriesD Liermann, H D Bottcher, J Kollath, et al.
Cellular Immunology|August 1, 1985
Antigens associated with the activation of murine mononuclear phagocytes in vivo: differential expression of lymphocyte function-associated antigen in the several stages of developmentG Strassmann, T A Springer, S J Haskill, et al.
Tumori|December 10, 1999
Clinical relevance of tumor ploidy and micronucleus formation for oral cavity cancerC Kolotas, C Tonus, D Baltas, et al.
Pageof 9

Showing results (61-70 of 84) with videos related to

Sort By:
Pageof 9
The Journal of Clinical Investigation|November 1, 1993
Suramin interferes with interleukin-6 receptor binding in vitro and inhibits colon-26-mediated experimental cancer cachexia in vivoG Strassmann, M Fong, C E Freter, et al.
Human Immunology|May 1, 1985
Analysis of human class II antigens by cloned cytolytic T cell reagents: a study using HLA loss mutant lymphoblastoid cell lines and monoclonal antibodies detecting the HLA-DP product(s)N Ohta, A Anichini, N L Reinsmoen, et al.
International Journal of Immunopharmacology|January 1, 1997
Vesnarinone inhibits immune-mediated but not Fas (CD95) agonist-mediated hepatic injuryD D Lazarus, T Kambayashi, M Yato-Kioka, et al.
Journal of the National Cancer Institute|September 18, 1996
Predominance of TH1 response in tumor-bearing mice and cancer patients treated with AS101B Sredni, T Tichler, A Shani, et al.
Annals of Surgical Oncology|January 1, 1996
Macrophage-derived tumor necrosis factor and tumor-derived of leukemia inhibitory factor and interleukin-6: possible cellular mechanisms of cancer cachexiaK G Billingsley, D L Fraker, G Strassmann, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 15, 1995
Effect of liposome-mediated macrophage depletion on LPS-induced cytokine gene expression and radioprotectionC A Salkowski, R Neta, T A Wynn, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1994
Inhibition of lipopolysaccharide and IL-1 but not of TNF-induced activation of human endothelial cells by suraminG Strassmann, N Graber, S M Goyert, et al.
Cardiovascular and Interventional Radiology|January 1, 1994
Prophylactic endovascular radiotherapy to prevent intimal hyperplasia after stent implantation in femoropopliteal arteriesD Liermann, H D Bottcher, J Kollath, et al.
Cellular Immunology|August 1, 1985
Antigens associated with the activation of murine mononuclear phagocytes in vivo: differential expression of lymphocyte function-associated antigen in the several stages of developmentG Strassmann, T A Springer, S J Haskill, et al.
Tumori|December 10, 1999
Clinical relevance of tumor ploidy and micronucleus formation for oral cavity cancerC Kolotas, C Tonus, D Baltas, et al.
Pageof 9